annual SGA:
$229.39M+$44.25M(+23.90%)Summary
- As of today (May 27, 2025), ARQT annual SGA is $229.39 million, with the most recent change of +$44.25 million (+23.90%) on December 31, 2024.
- During the last 3 years, ARQT annual SGA has risen by +$168.42 million (+276.23%).
- ARQT annual SGA is now at all-time high.
Performance
ARQT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$64.00M+$6.39M(+11.10%)Summary
- As of today (May 27, 2025), ARQT quarterly SGA is $64.00 million, with the most recent change of +$6.39 million (+11.10%) on March 31, 2025.
- Over the past year, ARQT quarterly SGA has increased by +$9.21 million (+16.80%).
- ARQT quarterly SGA is now at all-time high.
Performance
ARQT quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$4.45B-$129.72M(-3.00%)Summary
- As of today (May 27, 2025), ARQT TTM SGA is -$4.45 billion, with the most recent change of -$129.72 million (-3.00%) on March 31, 2025.
- Over the past year, ARQT TTM SGA has dropped by -$4.65 billion (-2358.50%).
- ARQT TTM SGA is now -18229.70% below its all-time high of -$24.28 million.
Performance
ARQT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ARQT Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.9% | +16.8% | -2358.5% |
| 3 y3 years | +276.2% | +190.8% | -6593.8% |
| 5 y5 years | +3370.4% | +1745.0% | -10000.0% |
ARQT Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +276.2% | at high | +190.8% | -197.1% | at low |
| 5 y | 5-year | at high | +3370.4% | at high | +1745.0% | -1976.8% | at low |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | <-9999.0% | at low |
ARQT Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $64.00M(+11.1%) | $238.60M(+4.0%) |
| Dec 2024 | $229.39M(+23.9%) | $57.61M(-2.1%) | $229.39M(+4.1%) |
| Sep 2024 | - | $58.82M(+1.1%) | $220.46M(+5.4%) |
| Jun 2024 | - | $58.17M(+6.2%) | $209.24M(+6.2%) |
| Mar 2024 | - | $54.79M(+12.6%) | $197.02M(+6.4%) |
| Dec 2023 | $185.15M(+51.6%) | $48.67M(+2.3%) | $185.15M(+6.7%) |
| Sep 2023 | - | $47.59M(+3.6%) | $173.49M(+7.5%) |
| Jun 2023 | - | $45.96M(+7.1%) | $161.37M(+12.8%) |
| Mar 2023 | - | $42.92M(+15.9%) | $143.04M(+17.1%) |
| Dec 2022 | $122.12M(+100.3%) | $37.02M(+4.4%) | $122.12M(+17.6%) |
| Sep 2022 | - | $35.47M(+28.4%) | $103.83M(+22.4%) |
| Jun 2022 | - | $27.62M(+25.5%) | $84.83M(+23.8%) |
| Mar 2022 | - | $22.01M(+17.5%) | $68.52M(+12.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $60.97M(+185.8%) | $18.73M(+13.7%) | $60.97M(+24.6%) |
| Sep 2021 | - | $16.47M(+45.6%) | $48.93M(+28.7%) |
| Jun 2021 | - | $11.31M(-21.7%) | $38.02M(+17.6%) |
| Mar 2021 | - | $14.45M(+116.1%) | $32.32M(+51.5%) |
| Dec 2020 | $21.34M(+222.8%) | $6.69M(+20.3%) | $21.34M(+26.4%) |
| Sep 2020 | - | $5.56M(-1.0%) | $16.88M(+23.9%) |
| Jun 2020 | - | $5.62M(+61.9%) | $13.62M(+46.0%) |
| Mar 2020 | - | $3.47M(+55.1%) | $9.33M(+41.1%) |
| Dec 2019 | $6.61M(+268.2%) | $2.24M(-2.7%) | $6.61M(+32.8%) |
| Sep 2019 | - | $2.30M(+73.7%) | $4.98M(+85.9%) |
| Jun 2019 | - | $1.32M(+76.8%) | $2.68M(+97.7%) |
| Mar 2019 | - | $749.00K(+23.6%) | $1.35M(+123.6%) |
| Dec 2018 | $1.79M(+158.3%) | $606.00K | $606.00K |
| Dec 2017 | $695.00K | - | - |
FAQ
- What is Arcutis Biotherapeutics annual SGA?
- What is the all time high annual SGA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual SGA year-on-year change?
- What is Arcutis Biotherapeutics quarterly SGA?
- What is the all time high quarterly SGA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly SGA year-on-year change?
- What is Arcutis Biotherapeutics TTM SGA?
- What is the all time high TTM SGA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM SGA year-on-year change?
What is Arcutis Biotherapeutics annual SGA?
The current annual SGA of ARQT is $229.39M
What is the all time high annual SGA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual SGA is $229.39M
What is Arcutis Biotherapeutics annual SGA year-on-year change?
Over the past year, ARQT annual SGA has changed by +$44.25M (+23.90%)
What is Arcutis Biotherapeutics quarterly SGA?
The current quarterly SGA of ARQT is $64.00M
What is the all time high quarterly SGA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly SGA is $64.00M
What is Arcutis Biotherapeutics quarterly SGA year-on-year change?
Over the past year, ARQT quarterly SGA has changed by +$9.21M (+16.80%)
What is Arcutis Biotherapeutics TTM SGA?
The current TTM SGA of ARQT is -$4.45B
What is the all time high TTM SGA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM SGA is -$24.28M
What is Arcutis Biotherapeutics TTM SGA year-on-year change?
Over the past year, ARQT TTM SGA has changed by -$4.65B (-2358.50%)